New Study Debunks Claims: Injection Site Closure Did Not Increase Overdose Deaths
A recent study examining the aftermath of supervised injection site closures in Alberta has delivered a surprising finding: contrary to widespread activist warnings, there was no increase in fatal overdoses following the shutdowns. This data challenges long-held assumptions about the necessity of these facilities in preventing overdose deaths.
The Data That Contradicts Activist Predictions
The research, published in March 2026, specifically analyzed overdose statistics in the months following the closure of injection sites that were located within 250 meters of schools and daycares. While harm reduction activists had predicted a dramatic spike in overdose deaths, the numbers tell a different story.
According to the Toronto Overdose Information System, monthly fatal overdoses have actually been lower every month since the last month those now-closed sites were operational, with only one exception. In January 2026, there were 12 fatal overdoses in Toronto, which aligns closely with the monthly average of 11 throughout 2025.
Examining the Non-Fatal Overdose Data
While emergency service calls for non-fatal overdoses did show an increase in December 2025 and January 2026, this uptick occurred eight months after the site closures. For the first eight months following the shutdowns, non-fatal overdose calls remained below or equal to 2024 levels.
"If some are going to argue that a drop in overdoses for almost a year has no bearing on the effectiveness of now-closed injection sites, is it not problematic to now blame Toronto's jump in non-fatal overdoses on the closure of the sites eight months after the fact?" questioned the study's author, highlighting what appears to be selective interpretation of data by some harm reduction advocates.
Questioning the Foundation of Injection Site Research
The study raises fundamental questions about the scientific basis for supervised injection sites. Recent disclosures from a freedom of information request to Health Canada revealed that when the federal agency renewed the exemption for Toronto's South Riverdale Community Health Centre injection site in November 2024, it did so despite overwhelming opposition from more than 200 local residents and businesses surveyed.
Health Canada justified its decision by citing injection sites as "evidence-based" services that "reduced drug-related harms" and improved "the health of drug users" through referrals to treatment and other services. However, the new study suggests this evidence may be less conclusive than previously presented.
The Legal and Community Context
The research emerges against a backdrop of legal challenges and community concerns. In late 2024, a Toronto injection site initiated litigation arguing that closing sites near schools and daycares violated the Charter rights of drug users. What became clear through this legal process was that the science on injection sites remains far from settled.
As communities across Canada grapple with the opioid crisis, this new data provides a crucial counterpoint to established narratives about harm reduction strategies. The findings suggest that the relationship between injection sites and overdose prevention may be more complex than previously understood, requiring more nuanced approaches to drug policy and public health interventions.
